Debiopharm Innovation Fund

Summary

The leading representative office of defined VC is situated in the Martigny. The venture was found in Europe in Switzerland.

Among the most popular fund investment industries, there are Search Engine, MOOC. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. Among the most popular portfolio startups of the fund, we may highlight Kaiku Health, Diagnoplex, BC Platforms.

This organization was formed by Tanja Dowe. We also calculated 4 valuable employees in our database.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Debiopharm Innovation Fund, startups are often financed by Venture Kick, Johnson & Johnson Development Corporation, Debiopharm Group. The meaningful sponsors for the fund in investment in the same round are Tesi, Wellcome Trust, Valiance Asset Management. In the next rounds fund is usually obtained by Truffle Capital, Swisscom Ventures, Serena.

The top amount of exits for fund were in 2015. The common things for fund are deals in the range of 10 - 50 millions dollars. This Debiopharm Innovation Fund works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2013. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 36 percentage points more often commits exit comparing to other companies.